| Schedule of Segment Information |
The following table summarizes certain information regarding segments of the Company's operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
|
|
|
| (in thousands) |
2023 |
|
2022 |
|
|
|
|
|
|
|
|
| Net sales |
|
|
|
|
|
|
|
|
|
|
|
| Tubular Products |
$ |
58,653 |
|
|
$ |
88,383 |
|
|
|
|
|
|
|
|
|
| Specialty Chemicals |
23,749 |
|
|
27,721 |
|
|
|
|
|
|
|
|
|
| All Other |
50 |
|
|
114 |
|
|
|
|
|
|
|
|
|
|
$ |
82,452 |
|
|
$ |
116,218 |
|
|
|
|
|
|
|
|
|
| Operating income (loss) |
|
|
|
|
|
|
|
|
|
|
|
| Tubular Products |
$ |
(2,504) |
|
|
$ |
14,574 |
|
|
|
|
|
|
|
|
|
| Specialty Chemicals |
1,352 |
|
|
2,387 |
|
|
|
|
|
|
|
|
|
| All Other |
(479) |
|
|
(82) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Corporate |
|
|
|
|
|
|
|
|
|
|
|
| Unallocated corporate expenses |
(3,704) |
|
|
(3,029) |
|
|
|
|
|
|
|
|
|
| Acquisition costs and other |
(259) |
|
|
(531) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Earn-out adjustments |
— |
|
|
(102) |
|
|
|
|
|
|
|
|
|
| Total Corporate |
(3,963) |
|
|
(3,662) |
|
|
|
|
|
|
|
|
|
| Operating income (loss) |
(5,594) |
|
|
13,217 |
|
|
|
|
|
|
|
|
|
| Interest expense |
1,107 |
|
|
403 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other, net |
(95) |
|
|
(35) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Income (loss) before income taxes |
$ |
(6,606) |
|
|
$ |
12,849 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of |
|
|
|
|
|
|
| (in thousands) |
March 31, 2023 |
|
December 31, 2022 |
|
|
|
|
|
|
|
|
| Identifiable assets |
|
|
|
|
|
|
|
|
|
|
|
| Tubular Products |
$ |
145,416 |
|
|
$ |
158,664 |
|
|
|
|
|
|
|
|
|
| Specialty Chemicals |
70,406 |
|
|
72,990 |
|
|
|
|
|
|
|
|
|
| Corporate |
39,210 |
|
|
37,389 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
255,032 |
|
|
$ |
269,043 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|